N,N'-(3,6,9,12,15,18-Hexaoxaicosane-1,20-diyl)bis(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamide)

Catalog No. :
ACTOJV165
CAS No. :
2458811-07-7
Molecular Formula :
C28H42N4O12
Molecular Weight :
626.66

IUPAC Name:N,N'-(3,6,9,12,15,18-hexaoxaicosane-1,20-diyl)bis(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamide)

N,N'-(3,6,9,12,15,18-Hexaoxaicosane-1,20-diyl)bis(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamide) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$595.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,N'-(3,6,9,12,15,18-Hexaoxaicosane-1,20-diyl)bis(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamide)
IUPAC NameN,N'-(3,6,9,12,15,18-hexaoxaicosane-1,20-diyl)bis(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamide)
Molecular FormulaC28H42N4O12
Molecular Weight626.66
SMILESO=C(NCCOCCOCCOCCOCCOCCOCCNC(CCN1C(C=CC1=O)=O)=O)CCN2C(C=CC2=O)=O
InChI KeyGPXKZMBVSUHQLW-UHFFFAOYSA-N
SynonymBis-Mal-PEG6;Bis-Mal-amido-PEG6;1H-Pyrrole-1-propanamide, N,N'-3,6,9,12,15,18-hexaoxaeicosane-1,20-diylbis[2,5-dihydro-2,5-dioxo-;N,N'-(3,6,9,12,15,18-hexaoxaicosane-1,20-diyl)bis(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamide)
CAS No.2458811-07-7

Synthetic Route by SureRoute

1. ACTOJV165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHMLB092 route compound structure diagram
    ACHMLB0927423-55-4 In Stock
  4. Then
  5. ACTOJV165 route product structure diagram
    ACTOJV1652458811-07-7
Inquiry

2. ACTOJV165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTOJV165 route product structure diagram
    ACTOJV1652458811-07-7
Inquiry

Comments (0)